Scott Dunseth Myers

Insider Reports History

Entity
Individual
Location
C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, Washington
Signature
Scott Dunseth Myers, by /s/ Trevor Dutcher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott Dunseth Myers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director Common Stock 260K $5.45M $21.00 Apr 12, 2023 Direct
DYNAVAX TECHNOLOGIES CORP Director Common Stock 25.4K $290K $11.39 May 23, 2024 Direct
DYNAVAX TECHNOLOGIES CORP Director Stock Option (Right to Buy) 22.5K May 23, 2024 Direct
Cartesian Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $0.79 Nov 13, 2023 Direct
Harpoon Therapeutics, Inc. Director Common Stock 0 Mar 11, 2024 Direct
Harpoon Therapeutics, Inc. Director Director Stock Option (Right to Buy) 0 Mar 11, 2024 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Scott Dunseth Myers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DVAX DYNAVAX TECHNOLOGIES CORP May 23, 2024 2 $0 4 May 28, 2024 Director
HARP Harpoon Therapeutics, Inc. Mar 11, 2024 3 $0 4 Mar 11, 2024 Director
HARP Harpoon Therapeutics, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
HARP Harpoon Therapeutics, Inc. Nov 27, 2023 1 $0 4 Nov 28, 2023 Director
SELB Cartesian Therapeutics, Inc. Nov 13, 2023 5 -$81.4K 4 Nov 15, 2023 Director
HARP Harpoon Therapeutics, Inc. Oct 1, 2023 1 $0 4 Oct 2, 2023 Director
HARP Harpoon Therapeutics, Inc. Jul 1, 2023 1 $0 4 Jul 6, 2023 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 26, 2023 2 $0 4 May 31, 2023 Director
VRDN Viridian Therapeutics, Inc.\DE Apr 12, 2023 1 $101K 4 Apr 12, 2023 Chief Executive Officer, Director
HARP Harpoon Therapeutics, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director
VRDN Viridian Therapeutics, Inc.\DE Mar 13, 2023 1 $160K 4 Mar 13, 2023 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE Feb 6, 2023 2 $0 4 Feb 7, 2023 Chief Executive Officer, Director
VRDN Viridian Therapeutics, Inc.\DE Feb 6, 2023 0 $0 3 Feb 7, 2023 Chief Executive Officer, Director
SELB SELECTA BIOSCIENCES INC Jan 2, 2023 1 $0 4 Jan 4, 2023 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
DVAX DYNAVAX TECHNOLOGIES CORP May 26, 2022 2 $0 4 May 27, 2022 Director
SELB SELECTA BIOSCIENCES INC Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
TRIL Trillium Therapeutics Inc. Nov 17, 2021 1 $0 4 Nov 19, 2021 Director
HARP Harpoon Therapeutics, Inc. Oct 25, 2021 1 $0 4 Oct 26, 2021 Director
DVAX DYNAVAX TECHNOLOGIES CORP Oct 19, 2021 2 $0 4 Oct 21, 2021 Director
DVAX DYNAVAX TECHNOLOGIES CORP Oct 19, 2021 0 $0 3 Oct 21, 2021 Director
HARP Harpoon Therapeutics, Inc. May 4, 2021 1 $0 4/A May 14, 2021 Director